Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2025Open Access

Adverse Drug Reactions in Oncology Patients Based on Global Evidence: A Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAshish K. Mishra

Discussion

Loading...

Member takes

Overview

Systematic review synthesizes evidence on adverse drug reactions and management strategies in oncology patients, highlighting risk factors.

Key Points

  • Adverse drug reactions occur frequently in oncology patients undergoing systemic anticancer therapies.
  • Platinum compounds, taxanes, and antimetabolites are the most commonly implicated agents for these reactions.
  • Advanced age, female sex, polypharmacy, and specific drug regimens are significant risk factors for adverse drug reactions.
  • Multidisciplinary care and personalized dosing strategies are essential to improve patient safety and treatment efficacy.

Cite This Study

Ashish K. Mishra (2025) studied this question.

synapsesocial.com/papers/68ed3352c8c3d6f5ff5dda3ehttps://doi.org/10.63363/aijfr.2025.v06i05.1464
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Occurrence of adverse drug reactions in chemotherapy patients: A cross-sectional study2026
  2. 2An insight into the adverse drug reactions considering causality, severity, preventability and adherence among patients receiving anticancer drugs at a North Indian rural tertiary care centre2025
  3. 3Pharmacotherapeutic Monitoring of Adverse Drug Reaction in Oncology Outpatient Clinics2026
  4. 4Scientific Analysis with a Retrospective Method on the Incidence and Severity of Adverse Drug Reactions in Hospitalized Cancer Patients2024
  5. 5Epidemiology of chemotherapy-related adverse drug reactions among patients with cancer in Ethiopia: A systematic review and meta-analysis2025 · 1 citations